Duality Advisers LP purchased a new position in Cooper Companies Inc (NYSE:COO) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 12,204 shares of the medical device company’s stock, valued at approximately $3,462,000.

A number of other hedge funds also recently bought and sold shares of the stock. Norges Bank purchased a new position in Cooper Companies during the fourth quarter valued at $153,518,000. Viking Global Investors LP acquired a new stake in Cooper Companies in the 1st quarter valued at about $120,464,000. Waddell & Reed Financial Inc. lifted its stake in Cooper Companies by 39,344.6% in the 1st quarter. Waddell & Reed Financial Inc. now owns 259,151 shares of the medical device company’s stock worth $71,440,000 after purchasing an additional 258,494 shares in the last quarter. Veritas Asset Management LLP boosted its holdings in shares of Cooper Companies by 12.9% during the 1st quarter. Veritas Asset Management LLP now owns 1,484,115 shares of the medical device company’s stock worth $409,126,000 after purchasing an additional 169,467 shares during the last quarter. Finally, Balyasny Asset Management LLC purchased a new stake in shares of Cooper Companies in the first quarter valued at approximately $23,189,000. 88.09% of the stock is currently owned by institutional investors.

Shares of NYSE COO opened at $282.93 on Friday. The company has a quick ratio of 0.58, a current ratio of 1.14 and a debt-to-equity ratio of 0.37. The business’s 50 day moving average is $288.34 and its two-hundred day moving average is $307.54. Cooper Companies Inc has a 52-week low of $236.68 and a 52-week high of $365.68. The firm has a market cap of $15.08 billion, a price-to-earnings ratio of 41.18, a PEG ratio of 3.04 and a beta of 0.91.

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.51 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.29 by ($0.78). Cooper Companies had a net margin of 13.50% and a return on equity of 14.67%. The firm had revenue of $524.90 million during the quarter, compared to analyst estimates of $604.78 million. During the same period in the previous year, the firm posted $2.94 earnings per share. The company’s quarterly revenue was down 19.7% compared to the same quarter last year. Analysts anticipate that Cooper Companies Inc will post 8.45 EPS for the current fiscal year.

The company also recently announced a Semi-Annual dividend, which will be paid on Friday, August 7th. Shareholders of record on Thursday, July 23rd will be given a $0.03 dividend. The ex-dividend date is Wednesday, July 22nd. Cooper Companies’s dividend payout ratio is currently 0.49%.

A number of brokerages recently commented on COO. Jefferies Financial Group reduced their price objective on Cooper Companies from $360.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Robert W. Baird lowered Cooper Companies from an “outperform” rating to a “neutral” rating and reduced their price target for the stock from $335.00 to $291.00 in a report on Monday, July 6th. TheStreet lowered shares of Cooper Companies from a “b” rating to a “c+” rating in a report on Thursday, June 4th. Stephens lifted their target price on shares of Cooper Companies from $300.00 to $325.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 26th. Finally, Oppenheimer assumed coverage on shares of Cooper Companies in a report on Friday, June 5th. They issued a “hold” rating and a $330.00 target price on the stock. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $330.25.

In other Cooper Companies news, SVP Agostino Ricupati purchased 1,000 shares of the company’s stock in a transaction on Thursday, June 11th. The stock was acquired at an average price of $281.47 per share, for a total transaction of $281,470.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Holly R. Sheffield purchased 355 shares of the company’s stock in a transaction on Wednesday, July 8th. The stock was acquired at an average price of $280.00 per share, with a total value of $99,400.00. Following the purchase, the executive vice president now owns 1,285 shares of the company’s stock, valued at $359,800. The disclosure for this purchase can be found here. Insiders have acquired 3,235 shares of company stock worth $908,298 over the last quarter. Insiders own 1.40% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Read More: Total Return

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.